ArticleJournal of diabetes investigation2017

Mechanism of lipid-lowering action of the dipeptidyl peptidase-4 inhibitor, anagliptin, in low-density lipoprotein receptor-deficient mice.

Wataru Yano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.